BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
71.44
-1.39 (-1.91%)
At close: Mar 28, 2025, 4:00 PM
69.00
-2.44 (-3.42%)
Pre-market: Mar 31, 2025, 8:43 AM EDT
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of $13.63 billion as of March 31, 2025. Its market cap has decreased by -14.79% in one year.
Market Cap
13.63B
Enterprise Value
13.13B
1-Year Change
-14.79%
Ranking
Category
Stock Price
$71.44
Market Cap Chart
Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $13.63B, an increase of 2,973.77%. That is a compound annual growth rate of 14.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 13.63B | 8.80% |
Dec 31, 2024 | 12.53B | -31.03% |
Dec 29, 2023 | 18.16B | -5.57% |
Dec 30, 2022 | 19.23B | 18.58% |
Dec 31, 2021 | 16.22B | 1.90% |
Dec 31, 2020 | 15.92B | 4.81% |
Dec 31, 2019 | 15.19B | 0.17% |
Dec 31, 2018 | 15.16B | -3.18% |
Dec 29, 2017 | 15.66B | 9.92% |
Dec 30, 2016 | 14.25B | -15.66% |
Dec 31, 2015 | 16.89B | 26.72% |
Dec 31, 2014 | 13.33B | 33.25% |
Dec 31, 2013 | 10.00B | 64.58% |
Dec 31, 2012 | 6.08B | 54.81% |
Dec 30, 2011 | 3.93B | 42.26% |
Dec 31, 2010 | 2.76B | 45.68% |
Dec 31, 2009 | 1.89B | 6.63% |
Dec 31, 2008 | 1.78B | -48.15% |
Dec 31, 2007 | 3.43B | 128.90% |
Dec 29, 2006 | 1.50B | 87.98% |
Dec 30, 2005 | 796.50M | 93.28% |
Dec 31, 2004 | 412.10M | -16.92% |
Dec 31, 2003 | 496.00M | 31.08% |
Dec 31, 2002 | 378.40M | -36.33% |
Dec 31, 2001 | 594.30M | 67.03% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |